Multicenter prospective study to optimize the efficacy of triple therapy with telaprevir in patients with genotype 1b hepatitis C virus infection according to an algorithm based on the drug Adherence, IL‐28B Gene Allele and Viral Response Trial (AG

Publisher： John Wiley & Sons Inc

E-ISSN： 1872-034x|45|11|1091-1099

ISSN： 1386-6346

Source： HEPATOLOGY RESEARCH, Vol.45, Iss.11, 2015-11, pp. : 1091-1099

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Factors associated with sustained virological response in 24‐week telaprevir‐based triple therapy for chronic hepatitis C genotype 1b patients with the IL28B minor genotype

By  

HEPATOLOGY RESEARCH, Vol. 45, Iss. 4, 2015-04 ,pp. : 387-396

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prediction of Sustained Virologic Response Based on Week 4 and Week 12 Response in Hepatitis C Virus Genotype 1 Patients Treated with Peginterferon and Ribavirin: Assessment in a Favorable IL28B Allele-Prevalent Area

By  

Intervirology, Vol. 56, Iss. 3, 2013-01 ,pp. : 178-183

Karger

Access to resources Recommend Favorite

Effectiveness of triple therapy with simeprevir for chronic hepatitis C genotype 1b patients with prior telaprevir failure

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. 12, 2015-12 ,pp. : 992-1001

John Wiley & Sons Inc

Access to resources Recommend Favorite

Variations in the Viral NS5B Region in Japanese Patients with Chronic Hepatitis C Virus Genotype 1b Infection

By  

Intervirology, Vol. 49, Iss. 6, 2006-10 ,pp. : 319-326

Karger

Access to resources Recommend Favorite

An Open Pilot Study Exploring the Efficacy of Fluvastatin, Pegylated Interferon and Ribavirin in Patients with Hepatitis C Virus Genotype 1b in High Viral Loads

By  

Intervirology, Vol. 52, Iss. 1, 2009-04 ,pp. : 43-48

Karger

Access to resources Recommend Favorite